2019 Publications

Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending.

Metes ID, Xue L, Chang C-CH, Huskamp HA, Gellad WF, Lo-Ciganic W-H, Choudhry NK, Richards-Shubik S, Guclu H, Donohue JM.

​

BMC Health Serv. Res 2019 Oct

Effect of Automated Immunization Registry-Based Telephonic Interventions on Adult Vaccination Rates in Community Pharmacies: A Randomized Controlled Trial.

Stolpe S, Choudhry NK.

 

Journal of Managed Care & Specialty Pharmacy 2019 Sep

A concept‐wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives.

Singh K, Choudhry NK, Krumme AA, McKay C, McElwee NE, Kimura J, Franklin JM. 

​

Pharmacoepidemiol Drug Saf. 2019 July

A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: clinical outcomes and cost-effectiveness analysis. 

D’Andrea E, Choudhry NK, Raby B, Weinhouse G, Najafzadeh M. 

 

Int J Cancer. 2019 April

Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial. 

Lauffenburger JC, Ghazinouri R, Jan S, Makanji S, Ferro CA, Lewey J, Wittbrodt E, Lee J, Haff N, Fontanet CP, Choudhry NK.

 

PLOS ONE 2019 April

Effect of Targeted Insulin Adherence Interventions for Glycemic Control With Predictive Analytics Among Patients With Type 2 Diabetes: The TARGIT-Diabetes Randomized Clinical Trial. 

Lauffenburger JC, Lewey J, Jan S, Makanji S, Ferro CA, Krumme AA, Lee J, Ghazinouri R, Haff N, Choudhry NK. 

​

JAMA Network Open 2019 March

Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis

Desai RJ, Mahesri M, Gagne JJ, Hurley E, Tong A, Chitnis T, Minden S, Spettell CM, Matlin OS, Shrank WH, Choudhry NK.

​

Journal of Managed Care and Specialty Pharmacy 2019 January 

​

Effect of medication co-payment vouchers on P2Y12 inhibitor use and major adverse cardiovascular events among patients with myocardial infarction: The ARTEMIS randomized clinical trial. 

Wang TY, Kaltenbach LA, Cannon CP, Fonarow GC, Choudhry NK, et al.

 

JAMA 2019 January

​